On February 6, 2024, the Federal Trade Commission (“FTC”) commented in support of what would be a historic expansion of government march-in rights under the Bayh-Dole Act in response to the release of the National Institute...more
2/13/2024
/ Bayh-Dole Act ,
Draft Guidance ,
Drug Pricing ,
Federal Trade Commission (FTC) ,
Healthcare ,
Innovation ,
Inventions ,
March-in-Rights ,
NIST ,
Pharmaceutical Industry ,
Prescription Drugs ,
R&D ,
Regulatory Agenda ,
Regulatory Reform
The battle between Mylan and Allergan over the six Orange Book patents covering Restasis has taken a next formal step. On Sept. 22, the new patent-owner, the Saint Regis Mohawk Tribe, moved to dismiss Mylan’s requests for...more
10/5/2017
/ Allergan Inc ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Mylan Pharmaceuticals ,
Native American Issues ,
Orange Book ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Industry ,
Sovereign Immunity ,
Tribal Governments
A revolutionary biotechnology tool is the focus of an intense biotechnology patent dispute that will have far-reaching impact in coming years. The dispute is over the rights to the CRISPR-cas9 system, a versatile molecular...more
In This Issue:
- Summary
- Case Analysis
- Implications
..Prokaryotic Nucleic Acid Sequences
..Short Segments of Eukaryotic DNA
..Promoters/Regulatory regions
..Isolated Proteins
...more
Originally published in TECHLI on December 9, 2012
The primary purposes of forming a corporate entity are to segregate individual liabilities from business liabilities, to create a structure for future investment in...more